Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

SHE:002728 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Cash & Equivalents	383.32	126.15	457.41	647.25	739.66	372.47
Trading Asset Securities	173	210	-	-	-	-
Cash & Short-Term Investments	556.32	336.15	457.41	647.25	739.66	372.47
Cash Growth	53.99%	-26.51%	-29.33%	-12.49%	98.58%	-35.24%
Accounts Receivable	148.6	253.59	205.32	156	133.02	126.66
Other Receivables	0.9	0.8	9.38	13.94	16.87	1.36
Receivables	149.51	254.39	214.7	169.94	149.9	128.02
Inventory	269.91	237.63	264.38	271.83	208.23	195.31
Prepaid Expenses	-	-	-	-	-	0.69
Other Current Assets	30.22	29.43	14.46	16.13	31.08	15.45
Total Current Assets	1,006	857.6	950.95	1,105	1,129	711.95
Property, Plant & Equipment	728.05	733.31	721.4	656.49	648.01	601.68
Long-Term Investments	13.5	13.5	13.5	13.5	13.5	-
Goodwill	517.6	517.6	517.6	529.23	542.4	542.4
Other Intangible Assets	135.37	141.22	138.63	151.24	153.87	156.75
Long-Term Deferred Tax Assets	21.68	28.43	21.85	18.4	18.81	17.18
Long-Term Deferred Charges	10.5	7.29	17.41	13.45	11.48	15.6
Other Long-Term Assets	16.7	12.47	19.54	25.18	28.67	20.65
Total Assets	2,449	2,311	2,401	2,513	2,546	2,066

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Accounts Payable	68.37	68.63	44.83	83	76.29	52.35
Accrued Expenses	11.89	40.62	19.37	32.5	30.42	20.09
Short-Term Debt	424.2	263.54	516.09	306	633.68	377
Current Portion of Long-Term Debt	-	-	-	-	213.5	-
Current Income Taxes Payable	2.03	3.92	0.72	13.65	4.86	8.59
Current Unearned Revenue	25.36	62.18	11.05	24.26	130.69	31.06
Other Current Liabilities	101.5	15.45	3.96	6.36	19.81	7.25
Total Current Liabilities	633.34	454.33	596.02	465.77	1,109	496.34
Long-Term Debt	-	-	-	-	-	285.18
Long-Term Unearned Revenue	18.14	17.27	20.57	20.77	18.51	11.72
Long-Term Deferred Tax Liabilities	18.25	18.36	19.36	15.42	14.71	11.27
Total Liabilities	669.73	489.96	635.94	501.95	1,142	804.51

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Common Stock	513.31	513.31	512.21	364.69	229.18	221.64
Additional Paid-In Capital	851.83	849.97	844.13	982	575.92	460.91
Retained Earnings	507.02	552.53	495.8	657.68	553.51	519.38
Treasury Stock	-99.51	-101.19	-93.86	-	-	-
Comprehensive Income & Other	6.98	6.85	6.65	6.31	44.53	59.75
Shareholders' Equity	1,780	1,821	1,765	2,011	1,403	1,262
Total Liabilities & Equity	2,449	2,311	2,401	2,513	2,546	2,066

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Total Debt	424.2	263.54	516.09	306	847.18	662.18
Net Cash (Debt)	132.12	72.61	-58.68	341.25	-107.52	-289.71
Net Cash Growth	157.75%	-	-	-	-	-
Net Cash Per Share	0.25	0.14	-0.11	0.74	-0.25	-0.72
Filing Date Shares Outstanding	510.74	499.58	500.58	510.56	449.27	434.42
Total Common Shares Outstanding	510.74	499.58	499.49	510.56	449.19	434.42
Working Capital	372.62	403.27	354.93	639.39	19.62	215.61
Book Value Per Share	3.48	3.65	3.53	3.94	3.12	2.90
Tangible Book Value	1,127	1,163	1,109	1,330	706.87	562.55
Tangible Book Value Per Share	2.21	2.33	2.22	2.61	1.57	1.29
Buildings	608.42	608.2	527.78	542.22	412.29	419.33
Machinery	453.19	439.2	418.7	329.97	259.01	254.01
Construction In Progress	128.09	118.38	157.88	131.95	280.88	198.46

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error